COPD guidelines used by primary care in United Kingdom

About the national guidelines most used by primary care:

Chronic obstructive pulmonary disease (updated) (CG101)

Link to access these guidelines:

http://www.nice.org.uk/guidance/index.jsp?action=byID&o=13029

Year these guidelines were last updated:

2010

Evidence based methodology used to develop theses guidelines:

AGREE

More information about how NICE develop guidelines is available at http://www.nice.org.uk/aboutnice/howwework/

developingniceclinicalguidelines/developing_nice_clinical_guidelines.jsp

Name and type of agency responsible for developing these guidelines:

National Institute for Health and Care Excellence (NICE) which is a National Health Technology Assessment (HTA) organization

How primary care was involved in developing these national guidelines:

Primary care representatives were involved in the development

IPCRG involvement in developing these national guidelines:

No

Requirements or incentives in place for primary care to use these guidelines:

There is some financial incentivisation from the quality outcome framework (QOF COPD 8: The percentage of patients with COPD who have had influenza immunisation in the preceding 1 September to 31 March. QOF COPD10: The percentage of patients with COPD with a record of FeV1 in the previous 15 months)

Published information on implementation of these guidelines:

None

National agency responsible for validating guidelines are evidence based:

NHS Evidence is a part of NICE and organizations that produce guidelines can submit them to NHS evidence to be accredited as conforming to sufficiently high standards. They then have the same status as guidelines developed by NICE: http://www.nice.org.uk/aboutnice/aboutnhsevidence.jsp

Have these guidelines been validated by this agency:

Yes (because NICE has actually developed it, which gives automatic accredited status)

About other guidelines for COPD also used:

NICE publishes clinical knowledge summaries which are brief guidance aimed at a primary care audience on a range of issues including respiratory topics.  For COPD see: http://cks.nice.org.uk/chronic-obstructive-pulmonary-disease#azTab

International guidelines also used:

GOLD

Has the translation of these international guidelines been validated and if so by which agency:

Not applicable

Other information:

 

  • No labels